Report Detail
Global Ziprasidone Mesylate for Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4736701 |
- 24 August, 2026 |
- Global |
- 97 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Ziprasidone Mesylate for Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Ziprasidone mesylate for injection is an injectable formulation of the atypical antipsychotic medication ziprasidone, specifically designed for the rapid treatment of acute episodes of schizophrenia and bipolar disorder. It is delivered via intramuscular injection, providing a quick onset of action to help manage severe psychiatric symptoms.
This report is a detailed and comprehensive analysis for global Ziprasidone Mesylate for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ziprasidone Mesylate for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ziprasidone Mesylate for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ziprasidone Mesylate for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ziprasidone Mesylate for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ziprasidone Mesylate for Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ziprasidone Mesylate for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Viatris, Pfizer, Dr. Reddy's Laboratories, Gland Pharma, Chongqing Shenghuaxi Pharmaceutical, Jiangsu Nhwa Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ziprasidone Mesylate for Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Original Drug
Generic Drug
Market segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Major players covered
Viatris
Pfizer
Dr. Reddy's Laboratories
Gland Pharma
Chongqing Shenghuaxi Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ziprasidone Mesylate for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ziprasidone Mesylate for Injection, with price, sales quantity, revenue, and global market share of Ziprasidone Mesylate for Injection from 2021 to 2026.
Chapter 3, the Ziprasidone Mesylate for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ziprasidone Mesylate for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ziprasidone Mesylate for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ziprasidone Mesylate for Injection.
Chapter 14 and 15, to describe Ziprasidone Mesylate for Injection sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Ziprasidone Mesylate for Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Original Drug
- 1.3.3 Generic Drug
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Ziprasidone Mesylate for Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital Pharmacy
- 1.4.3 Retail Pharmacy
- 1.4.4 Online Pharmacy
- 1.5 Global Ziprasidone Mesylate for Injection Market Size & Forecast
- 1.5.1 Global Ziprasidone Mesylate for Injection Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Ziprasidone Mesylate for Injection Sales Quantity (2021-2032)
- 1.5.3 Global Ziprasidone Mesylate for Injection Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Viatris
- 2.1.1 Viatris Details
- 2.1.2 Viatris Major Business
- 2.1.3 Viatris Ziprasidone Mesylate for Injection Product and Services
- 2.1.4 Viatris Ziprasidone Mesylate for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Viatris Recent Developments/Updates
- 2.2 Pfizer
- 2.2.1 Pfizer Details
- 2.2.2 Pfizer Major Business
- 2.2.3 Pfizer Ziprasidone Mesylate for Injection Product and Services
- 2.2.4 Pfizer Ziprasidone Mesylate for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Pfizer Recent Developments/Updates
- 2.3 Dr. Reddy's Laboratories
- 2.3.1 Dr. Reddy's Laboratories Details
- 2.3.2 Dr. Reddy's Laboratories Major Business
- 2.3.3 Dr. Reddy's Laboratories Ziprasidone Mesylate for Injection Product and Services
- 2.3.4 Dr. Reddy's Laboratories Ziprasidone Mesylate for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
- 2.4 Gland Pharma
- 2.4.1 Gland Pharma Details
- 2.4.2 Gland Pharma Major Business
- 2.4.3 Gland Pharma Ziprasidone Mesylate for Injection Product and Services
- 2.4.4 Gland Pharma Ziprasidone Mesylate for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Gland Pharma Recent Developments/Updates
- 2.5 Chongqing Shenghuaxi Pharmaceutical
- 2.5.1 Chongqing Shenghuaxi Pharmaceutical Details
- 2.5.2 Chongqing Shenghuaxi Pharmaceutical Major Business
- 2.5.3 Chongqing Shenghuaxi Pharmaceutical Ziprasidone Mesylate for Injection Product and Services
- 2.5.4 Chongqing Shenghuaxi Pharmaceutical Ziprasidone Mesylate for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Chongqing Shenghuaxi Pharmaceutical Recent Developments/Updates
- 2.6 Jiangsu Nhwa Pharmaceutical
- 2.6.1 Jiangsu Nhwa Pharmaceutical Details
- 2.6.2 Jiangsu Nhwa Pharmaceutical Major Business
- 2.6.3 Jiangsu Nhwa Pharmaceutical Ziprasidone Mesylate for Injection Product and Services
- 2.6.4 Jiangsu Nhwa Pharmaceutical Ziprasidone Mesylate for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Ziprasidone Mesylate for Injection by Manufacturer
- 3.1 Global Ziprasidone Mesylate for Injection Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Ziprasidone Mesylate for Injection Revenue by Manufacturer (2021-2026)
- 3.3 Global Ziprasidone Mesylate for Injection Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Ziprasidone Mesylate for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Ziprasidone Mesylate for Injection Manufacturer Market Share in 2025
- 3.4.3 Top 6 Ziprasidone Mesylate for Injection Manufacturer Market Share in 2025
- 3.5 Ziprasidone Mesylate for Injection Market: Overall Company Footprint Analysis
- 3.5.1 Ziprasidone Mesylate for Injection Market: Region Footprint
- 3.5.2 Ziprasidone Mesylate for Injection Market: Company Product Type Footprint
- 3.5.3 Ziprasidone Mesylate for Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Ziprasidone Mesylate for Injection Market Size by Region
- 4.1.1 Global Ziprasidone Mesylate for Injection Sales Quantity by Region (2021-2032)
- 4.1.2 Global Ziprasidone Mesylate for Injection Consumption Value by Region (2021-2032)
- 4.1.3 Global Ziprasidone Mesylate for Injection Average Price by Region (2021-2032)
- 4.2 North America Ziprasidone Mesylate for Injection Consumption Value (2021-2032)
- 4.3 Europe Ziprasidone Mesylate for Injection Consumption Value (2021-2032)
- 4.4 Asia-Pacific Ziprasidone Mesylate for Injection Consumption Value (2021-2032)
- 4.5 South America Ziprasidone Mesylate for Injection Consumption Value (2021-2032)
- 4.6 Middle East & Africa Ziprasidone Mesylate for Injection Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Ziprasidone Mesylate for Injection Sales Quantity by Type (2021-2032)
- 5.2 Global Ziprasidone Mesylate for Injection Consumption Value by Type (2021-2032)
- 5.3 Global Ziprasidone Mesylate for Injection Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Ziprasidone Mesylate for Injection Sales Quantity by Application (2021-2032)
- 6.2 Global Ziprasidone Mesylate for Injection Consumption Value by Application (2021-2032)
- 6.3 Global Ziprasidone Mesylate for Injection Average Price by Application (2021-2032)
7 North America
- 7.1 North America Ziprasidone Mesylate for Injection Sales Quantity by Type (2021-2032)
- 7.2 North America Ziprasidone Mesylate for Injection Sales Quantity by Application (2021-2032)
- 7.3 North America Ziprasidone Mesylate for Injection Market Size by Country
- 7.3.1 North America Ziprasidone Mesylate for Injection Sales Quantity by Country (2021-2032)
- 7.3.2 North America Ziprasidone Mesylate for Injection Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Ziprasidone Mesylate for Injection Sales Quantity by Type (2021-2032)
- 8.2 Europe Ziprasidone Mesylate for Injection Sales Quantity by Application (2021-2032)
- 8.3 Europe Ziprasidone Mesylate for Injection Market Size by Country
- 8.3.1 Europe Ziprasidone Mesylate for Injection Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Ziprasidone Mesylate for Injection Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Ziprasidone Mesylate for Injection Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Ziprasidone Mesylate for Injection Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Ziprasidone Mesylate for Injection Market Size by Region
- 9.3.1 Asia-Pacific Ziprasidone Mesylate for Injection Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Ziprasidone Mesylate for Injection Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Ziprasidone Mesylate for Injection Sales Quantity by Type (2021-2032)
- 10.2 South America Ziprasidone Mesylate for Injection Sales Quantity by Application (2021-2032)
- 10.3 South America Ziprasidone Mesylate for Injection Market Size by Country
- 10.3.1 South America Ziprasidone Mesylate for Injection Sales Quantity by Country (2021-2032)
- 10.3.2 South America Ziprasidone Mesylate for Injection Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Ziprasidone Mesylate for Injection Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Ziprasidone Mesylate for Injection Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Ziprasidone Mesylate for Injection Market Size by Country
- 11.3.1 Middle East & Africa Ziprasidone Mesylate for Injection Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Ziprasidone Mesylate for Injection Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Ziprasidone Mesylate for Injection Market Drivers
- 12.2 Ziprasidone Mesylate for Injection Market Restraints
- 12.3 Ziprasidone Mesylate for Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Ziprasidone Mesylate for Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Ziprasidone Mesylate for Injection
- 13.3 Ziprasidone Mesylate for Injection Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Ziprasidone Mesylate for Injection Typical Distributors
- 14.3 Ziprasidone Mesylate for Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Ziprasidone Mesylate for Injection. Industry analysis & Market Report on Ziprasidone Mesylate for Injection is a syndicated market report, published as Global Ziprasidone Mesylate for Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Ziprasidone Mesylate for Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
